BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2471791)

  • 1. Antigenicity of the measles virus haemagglutinin studied by using synthetic peptides.
    Mäkelä MJ; Lund GA; Salmi AA
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():603-14. PubMed ID: 2471791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of immune response to synthetic peptides derived from the hemagglutinin of measles virus.
    Meqdam M; Mostratos A
    New Microbiol; 2000 Apr; 23(2):113-8. PubMed ID: 10872680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antibody response to synthetic peptides derived from the fusion protein of measles virus.
    Meqdam M; Mostratos A
    New Microbiol; 1999 Jan; 22(1):19-25. PubMed ID: 10190113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides.
    Obeid OE; Partidos CD; Steward MW
    Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against measles virus haemagglutinin react with synthetic peptides.
    Mäkelä MJ; Salmi AA; Norrby E; Wild TF
    Scand J Immunol; 1989 Aug; 30(2):225-31. PubMed ID: 2474850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.
    Ziegler D; Fournier P; Berbers GA; Steuer H; Wiesmüller KH; Fleckenstein B; Schneider F; Jung G; King CC; Muller CP
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2479-89. PubMed ID: 8887481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein.
    Muller CP; Schroeder T; Tu R; Brons NH; Jung G; Schneider F; Wiesmüller KH
    Scand J Immunol; 1993 Nov; 38(5):463-71. PubMed ID: 7694357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iscom immunization with synthetic peptides representing measles virus hemagglutinin.
    Pedersen IR; Bøg-Hansen TC; Dalsgaard K; Heegaard PM
    Virus Res; 1992 Jul; 24(2):145-59. PubMed ID: 1529642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus.
    Obeid OE; Partidos CD; Steward MW
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2549-57. PubMed ID: 7506296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
    Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
    Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.
    Nick S; Klaws J; Friebel K; Birr C; Hunsmann G; Bayer H
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():77-83. PubMed ID: 1689371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of human T cells specific for measles virus haemagglutinin and nucleocapsid.
    Ilonen J; Mäkelä MJ; Ziola B; Salmi AA
    Clin Exp Immunol; 1990 Aug; 81(2):212-7. PubMed ID: 1696862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
    El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
    J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites.
    Atassi MZ; Kurisaki J
    Immunol Commun; 1984; 13(6):539-51. PubMed ID: 6085322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell recognition of measles virus haemagglutinin studied in a mouse model.
    Mäkelä MJ; Smith RH; Lund GA; Salmi AA
    Scand J Immunol; 1989 May; 29(5):597-607. PubMed ID: 2786244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic characterization of measles and SSPE virus haemagglutinin by monoclonal antibodies.
    ter Meulen V; Löffler S; Carter MJ; Stephenson JR
    J Gen Virol; 1981 Dec; 57(Pt 2):357-64. PubMed ID: 6172558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies.
    Sheshberadaran H; Norrby E; McCullough KC; Carpenter WC; Orvell C
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1381-92. PubMed ID: 2425047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins.
    Partidos CD; Stanley CM; Steward MW
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1293-9. PubMed ID: 1710646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.
    Schlereth B; Germann PG; ter Meulen V; Niewiesk S
    J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monospecific antibody to the haemagglutinin of measles virus.
    McFarlin DE; Bellini WJ; Mingioli ES; Behar TN; Trudgett A
    J Gen Virol; 1980 Jun; 48(Pt 2):425-9. PubMed ID: 6156998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.